Cagent Vascular Announces CE Mark of Serranator, Next Generation Device for Vessel Dilatation in Peripheral Artery Disease Interventions

By Natalie GoodridgeNovember 20, 2017October 29th, 2024Healthcare

Cagent Vascular Announces CE Mark of Serranator, Next Generation Device for Vessel Dilatation in Peripheral Artery Disease Interventions

https://www.businesswire.com/news/home/20171120005812/en/Cagent-Vascular-Announces-CE-Mark-of-Serranator-Next-Generation-Device-for-Vessel-Dilatation-in-Peripheral-Artery-Disease-Interventions

Cagent Vascular Announces CE Mark of Serranator, Next Generation Device for Vessel Dilatation in Peripheral Artery Disease Interventions

Cagent Vascular Announces CE Mark of Serranator, Next Generation Device for Vessel Dilatation in Peripheral Artery Disease Interventions

Tags:

PreviousGecko Biomedical Builds Out Strategy For 'Print On' Polymers Platform

NextCorWave Receives 2017 Deloitte ‘Technology Fast 50 Biotech of the Future’ Award of the Parisian Region

M&L GROUP

We are a family investment firm that cultivates pioneering ventures into successful enterprises with passion, energy and integrity.

Hospitality

Healthcare

Shipping

Alternatives

Media room

About

Contact